Estrella Immunopharma Warrant
ESLAW
12 hedge funds and large institutions have $208K invested in Estrella Immunopharma Warrant in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 10 → 12 (+2)
0.11% more ownership
Funds ownership: 2.02% → 2.13% (+0.11%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
20% less capital invested
Capital invested by funds: $262K → $208K (-$53.7K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$1.8K |
| 2 |
CS
Clear Street
New York
|
+$267 |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$110 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$157 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $182K | – | – | – |
|
|
ASM
2
ATW SPAC Management
New York
| $7.59K | – | – | – |
|
3
D.E. Shaw & Co
New York
| $3.81K | – | – | – |
|
4
Walleye Trading
New York
| $3.46K | – | – | – |
|
|
SIA
5
SkyView Investment Advisors
Shrewsbury,
New Jersey
| $3K | – | – | – |
|
|
YCM
6
Yakira Capital Management
Westport,
Connecticut
| $2.21K | – | – | – |
|
|
WA
7
Whitebox Advisors
Minneapolis,
Minnesota
| $2.01K | – | – | – |
|
|
8
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $1.7K | +$1.8K | +35,815 | New |
|
|
CS
9
Clear Street
New York
| $1.61K | +$267 | +5,291 | +18% |
|
|
LCM
10
Landscape Capital Management
Englewood,
New Jersey
| $650 | – | – | – |
|
|
WAM
11
Wolverine Asset Management
Chicago,
Illinois
| $104 | +$110 | +2,191 | New |
|
|
12
UBS Group
Zurich,
Switzerland
| $47 | -$157 | -3,121 | -70% |
|
ESLAW Hedge Fund Activity: Q2 2025 in Review
12 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma Warrant (ESLAW) for Q2 2025, worth a combined $208K — down 20% from $262K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ESLAW positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Toronto Dominion Bank, opening a new position worth an estimated $1.8K. The largest seller was UBS Group, cutting an estimated $157.
- 12 institutional investors held Estrella Immunopharma Warrant (ESLAW) as of Q2 2025, up from 10 in Q1 2025.
- Funds reported $208K of Estrella Immunopharma Warrant stock for Q2 2025, down 20% quarter-over-quarter.
- 2 funds opened new Estrella Immunopharma Warrant positions in Q2 2025 and 0 closed out, a net change of +2 holders.
- The largest Estrella Immunopharma Warrant buyer in Q2 2025 was Toronto Dominion Bank, an estimated $1.8K added.
- The largest Estrella Immunopharma Warrant seller in Q2 2025 was UBS Group, an estimated $157 sold.
Based on aggregated 13F filings for Q2 2025.